It is a chemicals private limited company based in Kukatpally, Hyderabad, Telangana, India, established in 1996.
1996 | Kukatpally, Hyderabad, Telangana, India | ActiveNewfin Pharmaceuticals Private Limited, a active private limited company, was established on 17 January 1996 in Kukatpally, Hyderabad, Telangana, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24239TG1996PTC022898. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Suresh Adapa (Additional Director), Tamma Sandhya Rani (Additional Director). Past directors included Suresh Adapa, Bonthu Aruna, Bonthu Venkata Reddy. It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6-3, Sterling Emerald,Plot No.118, Bhagyanagar Colony,, Kukatpally, Hyderabad, Telangana.
U24239TG1996PTC022898
022898
17 January 1996
₹1.50 M
₹1.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Newfin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Adapa | Additional Director | 25 Aug 2015 | Current |
| Tamma Sandhya Rani | Additional Director | 01 Jul 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Jan 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
| Pramod Abcsdd | Managing Director | 03 Nov 2015 | Past |
| Pramod Abcsdd | Director | 20 Jun 2009 | Past |
| Pramod Abcsdd | Managing Director | 16 Jul 2011 | Past |
| Pramod Abcsdd | Director | 24 Jan 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Newfin Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 25.37% decrease. The company also saw a substantial fall in profitability, with a 1485.3% decrease in profit. The company's net worth dipped by a decrease of 5.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Newfin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2003 | Sbi | ₹1.00 M | Open |
| 02 Dec 1996 | Sbi | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Newfin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Newfin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newfin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Newfin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Newfin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on Tamma Sandhya Rani was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2016 & has been associated with this company since 9 years 5 months . was documented.
Suresh Adapa was appointed as a Additional Director was appointed as a Additional Director on 25 Aug 2015 & has been associated with this company since 10 years 3 months . was recorded as a recent event.
A charge with Sbi amounted to Rs. 1.00 M with Charge ID 90117840 was registered on 24 Jul 2003. was recorded as a recent event.
A charge with Sbi amounted to Rs. 2.00 M with Charge ID 90117177 was registered on 02 Dec 1996. was recorded as a recent event.
The CIN of Newfin Pharmaceuticals Private Limited is U24239TG1996PTC022898.
Newfin Pharmaceuticals Private Limited is headquartered at 6-3, Sterling Emerald,Plot No.118, Bhagyanagar Colony,, Kukatpally, Hyderabad, Telangana.
Newfin Pharmaceuticals Private Limited was incorporated on 17 January 1996.
The current directors of Newfin Pharmaceuticals Private Limited are
The primary industry of Newfin Pharmaceuticals Private Limited is Manufacturing.
Newfin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Newfin Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Newfin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX